SLR Investment Corp.
NASDAQ•SLRC
CEO: Mr. Michael Stuart Gross
セクター: Financial Services
業種: Asset Management
上場日: 2010-02-09
SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $100 million. The fund invests in companies with revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.
連絡先情報
500 Park Avenue, Third Floor, New York, NY, 10022-1606, United States
212-993-1670
時価総額
$816.14M
PER (TTM)
9.1
0
配当利回り
11.0%
52週高値
$17.94
52週安値
$13.64
52週レンジ
順位45Top 56.8%
3.6
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 3.6 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q3 2025 データ
売上高
$45.29M+4.11%
直近4四半期の推移
EPS
$0.43+7.50%
直近4四半期の推移
フリーCF
$45.85M-66.52%
直近4四半期の推移
2025 Q3 決算ハイライト
主なハイライト
NAV Per Share Stable NAV per share ended at $18.21 USD, a slight increase from $18.20 USD reported at December 31, 2024.
Strong Q3 Investment Activity Invested $276.9 M across 33 portfolio companies during the three months ended September 30, 2025 period.
Total Assets Reach $2.53 B Total assets grew to $2,529,892 K USD as of September 30, 2025, supporting total net assets of $993.287 M USD.
Lower Interest Income Nine months investment income fell to $164.083 M USD from $176.848 M USD in the prior comparable period.
リスク要因
Net Investment Income Decreases Nine months net investment income dropped to $65.340 M USD from $72.518 M USD due to lower index rates.
EPS Contraction Noted Earnings per share for nine months decreased to $1.24 USD compared to $1.34 USD reported previously.
Commitment Exposure Rises Total unfunded commitments increased significantly to $408.424 M USD as of September 30, 2025, from $234.554 M USD.
Non-Qualifying Assets Level Non-qualifying assets represented 27.9% of total assets on a fair value basis as of September 30, 2025.
見通し
Liquidity Capacity Maintained Company maintains $471.6 M of unused borrowing capacity across Credit Facility and SPV Credit Facility subject to limits.
Future Equity Issuance Available $150.0 M of common stock remains available for issuance and sale under the Equity Distribution Agreement.
Q4 Distribution Declared Board declared a quarterly distribution of $0.41 USD per share payable on December 26, 2025.
Debt Covenants Compliance Company confirmed compliance with all financial and operational covenants required by outstanding Debt Instruments.
同業比較
売上高 (TTM)
$393.79M
$192.05M
$191.10M
粗利益率 (最新四半期)
GAIN82.4%
79.9%
76.7%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| KBDC | $947.97M | 9.1 | 0.0% | 0.0% |
| BCSF | $873.78M | 9.4 | 8.2% | 0.0% |
| CGBD | $856.61M | 11.6 | 6.6% | 51.1% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
3.6%
緩やかな成長
4四半期純利益CAGR
1.0%
収益性の緩やかな改善
キャッシュフロー安定性
75%
キャッシュフローの変動が大きい
深度リサーチ
次回決算:2026年2月24日
EPS:$0.40
|売上高:$54.97M
財務レポート
財務データ
ニュース
全年度
Form 10-Q - Q3 2025
会計期末: 2025年9月30日|提出日: 2025年11月4日|売上高: $45.29M+4.1%|EPS: $0.43+7.5%予想通りForm 10-Q - Q2 2025
会計期末: 2025年6月30日|提出日: 2025年8月5日|売上高: $43.38M-1.3%|EPS: $0.44+2.3%予想通りForm 10-Q - Q1 2025
会計期末: 2025年3月31日|提出日: 2025年5月7日|売上高: $37.96M-21.4%|EPS: $0.37-27.5%予想を下回るForm 10-K - FY 2024
会計期末: 2024年12月31日|提出日: 2025年2月25日|売上高: $176.45M+10.9%|EPS: $1.76+25.7%予想を上回るForm 10-Q - Q3 2024
会計期末: 2024年9月30日|提出日: 2024年11月6日|売上高: $43.50M-11.9%|EPS: $0.40+1951.3%予想を下回るForm 10-Q - Q2 2024
会計期末: 2024年6月30日|提出日: 2024年8月7日|売上高: $43.95M+12.3%|EPS: $0.43+22.9%予想を下回るForm 10-Q - Q1 2024
会計期末: 2024年3月31日|提出日: 2024年5月8日|売上高: $48.28M+93.1%|EPS: $0.51+292.3%予想通りForm 10-K - FY 2023
会計期末: 2023年12月31日|提出日: 2024年2月27日|売上高: $159.05M+113.8%|EPS: $1.40+9.4%予想を上回る